Rankings
▼
Calendar
LGVN Q3 2024 Earnings — Longeveron Inc. Revenue & Financial Results | Market Cap Arena
LGVN
Longeveron Inc.
$20M
Q3 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$773,000
+415.3% YoY
Gross Profit
$682,000
88.2% margin
Operating Income
-$5M
-601.4% margin
Net Income
-$4M
-571.7% margin
EPS (Diluted)
$-0.34
QoQ Revenue Growth
+65.2%
Cash Flow
Operating Cash Flow
-$3M
Free Cash Flow
-$3M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$30M
Total Liabilities
$4M
Stockholders' Equity
$26M
Cash & Equivalents
$23M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$773,000
$150,000
+415.3%
Gross Profit
$682,000
$54,000
+1163.0%
Operating Income
-$5M
-$5M
+9.9%
Net Income
-$4M
-$5M
+13.5%
← FY 2024
All Quarters
Q4 2024 →